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Abstract
Background: Classical Swine Fever (CSFV) is one of the most important viral infectious diseases
affecting wild boars and domestic pigs. The etiological agent of the disease is the CSF virus, a single
stranded RNA virus belonging to the family Flaviviridae.
All preventive measures in domestic pigs have been focused in interrupting the chain of infection
and in avoiding the spread of CSFV within wild boars as well as interrupting transmission from wild
boars to domestic pigs. The use of plant based vaccine against CSFV would be advantageous as plant
organs can be distributed without the need of particular treatments such as refrigeration and
therefore large areas, populated by wild animals, could be easily covered.
Results: We report the in planta production of peptides of the classical swine fever (CSF) E2
glycoprotein fused to the coat protein of potato virus X. RT-PCR studies demonstrated that the
peptide encoding sequences are correctly retained in the PVX construct after three sequential
passage in Nicotiana benthamiana plants. Sequence analysis of RT-PCR products confirmed that the
epitope coding sequences are replicated with high fidelity during PVX infection. Partially purified
virions were able to induce an immune response in rabbits.
Conclusion: Previous reports have demonstrated that E2 synthetic peptides can efficiently induce
an immunoprotective response in immunogenized animals. In this work we have showed that E2
peptides can be expressed in planta by using a modified PVX vector. These results are particularly
promising for designing strategies for disease containment in areas inhabited by wild boars.
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Background
Classical swine fewer (CSF) is an economically important
viral infectious disease affecting domestic pigs and wild
boars. Infected animals develop severe leukopenia and
immunosuppression accompanied by hemorrhagic
lesions, with a mortality of about 90% in infected young
pigs [1,2]. The etiological agent of the disease is the CSF
virus (CSFV syn. Hog cholera), a single-stranded RNA
virus belonging to the genus Pestivirus, family Flaviviridae
[3]. The genome of CSFV contains a single open reading
frame encoding for a polyprotein of approximately 4,000
aminoacids that is processed into four structural (the
nucleocapsid C and three envelope glycoproteins, Erns or
gp44/48, E1 or gp33 and E2 or gp55) and several non-
structural proteins by virus-encoded and cellular pro-
teases [4].
E2, the most immunogenic envelope glycoprotein, con-
tains four antigenic domains, from A to D [4-6] located
within the N-terminal region of the protein. The E2 region
between amino acid 690 and 910 contains the sites recog-
nized by an hyperimmune serum in pigs; it includes the
TAVSPTTLR motif, which is conserved in all strains of
CSFV, but is divergent from other pestiviruses such as
bovine viral diarrhea virus (BVDV) and border disease
virus (BDV) [4,7].
Transmission of CSFV may be either pig-to-pig or pig-to-
wild boar, or it may also occur through infected semen or
via an oral route through contaminated fresh, frozen or
cured pig meat products [8]. All preventive measures in
domestic pigs and in wild boars have been focused to
interrupt the chain of infection and to avoid the spread of
CSFV within wild boars as well as to interrupt transmis-
sion from wild boars to domestic pigs [9,10]. Epidemio-
logical controls are, however, complicated by the lack of
diagnostic tools specific for CSFV, mainly due to the high
similarity between CSFV and other pestiviruses [11].
The use of plants to produce vaccines is an emerging strat-
egy that may offers several advantages over conventional
vaccines [12,13]. Plants are not attacked by animal viruses
and therefore plant-based vaccines are safe for animals
and can be produced in non-sterile environments. In
addition, some plant organs can be transported or distrib-
uted over long distances without the need of particular
treatments such as refrigeration. Vaccination costs could
therefore be dramatically reduced and large areas, popu-
lated by wild animals, could be easily covered.
Among the available technologies to express foreign pro-
teins in plants, plant virions represent one of the most
advantageous systems for epitope presentation and purifi-
cation [14]. The macromolecular nature of virion aggre-
gates permits the development of easy procedures for
virion purification/concentration: in salty reaction, high
doses of peptide can be recovered by a simple centrifuga-
tion [15]. Moreover, peptide fused to coat proteins (CP)
have been reported to be able to induce a specific immu-
noglobulin G (IgG) response through a mechanism
involving co-stimulatory ability of antigen-presenting
cells [14,16].
The demonstration that parenteral administration of syn-
thetic peptides of the E2 is able to induce neutralizing
antibodies [4,7,17] has drawn attention to setting up cost
effective systems for epitope production. Uhde et al. [18]
and Marusic et al. [16] have demonstrated that short pep-
tides (<15 amino acids) can be expressed when directly
fused to the CP of potato virus X. In this study we have
explored the feasibility of expressing longer peptides (>40
amino acids) of the E2 protein fused to the coat protein of
PVX via 2A peptide from FMDV (Foot and Mouth Disease
Virus). RT-PCR and sequence analyses demonstrated that
this expression system is highly reliable. The potential of
such an expression system for vaccination procedures and
for enhancing the specificity of diagnostic tools is also dis-
cussed.
Results
Epitope coding sequence is correctly retained during virus 
replication
Since the integration of foreign sequences in the PVX
genome, or the modification of the CP, may cause
genomic rearrangements [18,19], we have verified the
integrity of the chimeric transcript. RT-PCR carried out
with PVX and epitope specific primers (Fig. 1, Table 1)
resulted in a single amplification product of the expected
size in cDNA samples derived from plants infected with
PVX6HisE212ACP or PVX6HisE222ACP plasmids (Fig. 2).
No amplification products were observed in samples
when the RT step was omitted (data not shown).
Cellular extracts from plants inoculated with plasmid
DNAs were used to infect new plants (second order infec-
tions) and those obtained from second order infected
plants to inoculate other plants (third order infections).
Only bands of the expected sizes were visualized in RT-
PCR experiments carried out on samples derived from
plants of second and third order infections. Figure 2
shows the results of RT-PCR experiments carried out on
mRNAs isolated from systemic leaves derived from third
order infections. These results demonstrated that the
epitope sequences are correctly retained during PVX repli-
cation. Direct sequencing of the RT-PCR products
obtained from the third-order samples, with PVX specific
primers, showed the absence of point mutations (data not
shown), leading to the conclusion that epitope coding
sequences were replicated with high fidelity during viral
infections.BMC Biotechnology 2006, 6:29 http://www.biomedcentral.com/1472-6750/6/29
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Both cleaved CP and epitope-CP uncleaved polyproteins 
are produced upon virus infections
Total soluble proteins, extracted from symptomatic leaves
15 dpi with PVX6His2ACP, PVX6HisE212ACP,
PVX6HisE222ACP constructs or from mock-infected
plants, were analyzed by Western blotting with a polyclo-
nal anti-CP antibody. The conformation of the 2A within
the P ribosome site may cause the cleavage of the nascent
chain with the subsequent release of the N terminal prod-
uct from the ribosome. Some ribosomes however will
continue to produce the downstream protein as a discrete
entity [20,21]. Processing of the 2A site in synthetic poly-
proteins can be incomplete and the proportion of cleaved
versus uncleaved polyprotein may vary depending on the
sequence context upstream the 2A site [20].
Translation of chimeric transcripts is therefore expected to
produce: i) a full length uncleaved polyprotein (Fig. 3), ii)
the N-terminal cleaved portion of the polyprotein and iii)
the CP cleaved protein corresponding to the C-terminal
portion of the polyprotein (Fig. 3). A single broad band of
about 31–34 kDa corresponding to the cleaved CP and to
the uncleaved 6His2ACP polyproteins, respectively, were
visualized in PVX6His2ACP samples (Fig. 4 A3 and B3).
PVX-derived vectors Figure 1
PVX-derived vectors. Schematic representation of PVX-derived vectors used. Primers are indicated in their specific anneal-
ing sites.
Table 1: Primer sequences. PVX and epitope-specific primers, including primer sequences and amplification product characteristics 
for PVX6His2ACP (A), PVX6HisE212ACP (B) and PVX6HisE222ACP (C).
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Accordingly, in Western blotting of N. benthamiana
infected with a similar PVX2A vector, Santa Cruz et al.
[22], detected the cleaved CP protein at 31 kDa.
In PVX6HisE212ACP-infected samples, two bands of
about 31 and 42 kDa were visualized (Fig. 4 A1). These
bands likely correspond to the cleaved CP protein and to
the uncleaved 6HisE212ACP protein, respectively (Fig.
3A–C). In PVX6HisE222ACP-infected samples, the 37 and
31 kDa bands (Fig. 4 B1) correspond to the uncleaved
6HisE222ACP polyprotein and to the cleaved CP protein,
respectively (Fig. 3D–F). No bands were visualized in the
sample of mock infected plants (Fig. 4 A2, B2, C2 and
D2).
Duplicate blots were also probed with an anti-6His anti-
body. Only a single band of 42 kDa and 37 kDa were vis-
ualized in PVX6HisE212ACP and PVX6HisE222ACP-
infected samples (Fig. 4 C1 and D1). While a signal of
about 34 kDa was visualized in PVX6His2ACP infected
plants (Fig. 4 C3 and D3), no signal was detected in unin-
fected plants (Fig. 4 C2 and D2). Bands of about 11 and 6
kDa, corresponding to the predicted molecular weights
for 6HisE212A and 6HisE222A were never observed. These
results demonstrate that the PVX6His-recombinant vec-
tors are able to drive the expression of an uncleaved 6His-
epitope-2ACP polyprotein.
Recombinant virions can be partially purified by 
centrifugation
Recombinant virions were partially purified by centrifuga-
tion of cellular extracts from PVX6His2ACP and
PVX6HisE212ACP infected plants after incubation on ice
for 2 h in presence of 8% PEG-8000 as reported by Abou-
Haidar et al. [23]. The purification yielded about 150 and
120 µg of virus particles per gram of leaves infected with
PVX6His2ACP and PVX6HisE212ACP, respectively. An
aliquot of 250 ng of purified protein for each construct
was fractionated by SDS-PAGE and stained with Comassie
Brilliant Blue. Two bands of 42 and 31 kDa were visual-
ized over a very weak background (Fig. 5A). The 42
kDa:31 kDa relative amount, quantified with GeneSnap
software (Syngene), was 1:2. Western blotting with anti-
6His (Fig. 5B upper) and anti-CP (Fig. 5B lower) antibod-
ies confirmed that these bands correspond to the
uncleaved 6HisE212ACP polyprotein and to cleaved CP
protein.
Epitope E21 fused to the PVX CP protein is immunogenic
To verify that the epitopes produced in planta are immu-
nogenic, rabbits were immunized with 50 µg of purified
PVX6HisE212ACP virions (group A) or with purified
PVX6His2ACP (group C). The presence of anti-E2 anti-
bodies in rabbit sera was tested by Western analyses of
purified E2 proteins. Western blotting tests were per-
formed with serial dilutions of sera from rabbit immu-
nized with PVX6HisE212ACP (Fig. 6A–D) and
PVX6His2ACP (Fig. 6E–H). The E2 specific band was
detected with a PVX6HisE212ACP sera dilution up to 1/
100 (Fig. 6A–D) but not with PVX6His2ACP at any dilu-
tion (Fig. 6E–H). To verify the immunogenic response of
rabbits inoculated with PVX6His2ACP proteins (Fig. 5C),
western blotting analysis were carried out using their sera
against proteins purified from mock-inoculated control
plants (Fig. 5 C1) and from plants infected with
PVX6His2ACP (Fig. 5 C2). As shown in Figure 5D, a 55
kDa band, corresponding to the E2 protein, was visual-
ized in blots probed with rabbit sera but not in duplicate
blots probed with pre-immune sera or sera bled from B
and C group rabbits (data not shown). The A group rabbit
sera recognized both the 42 kDa and 31 kDa proteins in
total protein extracts derived from PVX6HisE212ACP-
infected plants (Fig. 5D). These results suggest that the
PVX6HisE212ACP antibody is able to induce anti-E2 anti-
bodies in immunized rabbits.
Discussion
Plant virus-mediated expression of immunogenic pep-
tides gives several advantages over other available systems
for mass production of peptides including: i) the environ-
ments for virus infection require only a moderate sterility
(a phyto-pathogen proof greenhouse would be suffi-
cient), ii) the need for "cold chains" from the producer to
the site of use of the vaccine may, in some cases, be
avoided for plant-derived vaccines [12] and iii) high doses
of peptide can be easily recovered from infected tissues
using basic laboratory equipment.
Expression analyses Figure 2
Expression analyses. RT-PCR of samples derived from 
third order infections' systemic leaves; the plants infected 
with PVX6His2ACP (A1 and B1), PVX6HisE212ACP (A2) and 
PVX6HisE222ACP (B2) vectors amplified with PVX FOR and 
PVX REW specific primers. Lane A3 shows the RT-PCR 
results for PVX6HisE212ACP using E21 FOR and E21 REW 
specific primers, whereas in lane B3 for PVX6HisE222ACP 
samples amplified by E22 FOR and E22 REW specific primers 
are shown. To evaluate the relative levels of mRNAs, the 
actin gene was used as an internal control (lower A and B 
panels). Each experiment was performed in triplicate.BMC Biotechnology 2006, 6:29 http://www.biomedcentral.com/1472-6750/6/29
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However, the reliability of this expression system can be
occasionally undermined due to several factors. First, viral
vectors have the tendency to lose the inserted sequences
after a number of replication rounds or plant passages
[14]. Second, a high error frequency has been observed
during viral RNA synthesis [24]. Detailed analysis of the
reliability of the expression levels achievable with these
systems is therefore advisable before large scale applica-
tions. Avesani et al. [25] have observed a drastic decline of
GAD 65, PVX-mediated expression levels after the first
passage in N. benthamiana plants and Ziegler et al. [19]
have shown that a scFv sequence inserted in a PVX vector
is completely deleted after the first round of infection.
Similar results were recently reported by Uhde et al. [18]
using PVX-based vectors.
In the present study, we have shown that a modified PVX
viral vector can be successfully used to express CSFV pep-
tides (70 aa for E21 and 40 aa for E22) linked to the N-ter-
minus of the PVX coat protein without compromising the
stability of virus during generations. Expression and
sequence analyses, carried out for three successive infec-
tion cycles, demonstrated that this expression system is
highly reliable. Moreover, rabbit immunization experi-
ments showed that recombinant virions are effective in
inducing antibodies.
Two factors may have contributed to the high stability of
the PVX construct used in this work: i) the presence of a
single subgenomic CP promoter may have reduced the
possibility for homologous recombination [26] and ii)
the co-presence of free and uncleaved CP protein may
have preserved an acceptable level of virus infectivity [22].
The other important advantage of the PVX expression sys-
tem is related to the co-stimulatory upregulation achieved
by peptides linked to the PVX coat protein. Since this
effect has been demonstrated for two independent pro-
teins, namely scFv [27] and HIV [16], it is possible that
this reflects a feature inherent to the PVX coat protein or,
alternatively, it could be due to the form in which it is pre-
sented.
Putative proteins produced Figure 3
Putative proteins produced. Possible translation products of PVX6His2ACP (A), PVX6HisE212ACP (D) and 
PVX6HisE222ACP (G). The small arrows indicate where the polyprotein is expected to cleaved at the carboxyl terminus of the 
2A. The PVX6His2ACP messenger (A) will be translated either into an uncleaved polyprotein (B) or into two cleaved subunits: 
6His2A and CP, respectively (C). The same holds true for the PVX6HisE212ACP (D), which could be translated into an 
uncleaved polyprotein (E) or into two cleaved subunits: 6HisE212A and CP, respectively (F). Either an uncleaved polyprotein 
(H) or two cleaved subunits (I) 6HisE222A and CP are expected to be translated from PVX6HisE222ACP (G).BMC Biotechnology 2006, 6:29 http://www.biomedcentral.com/1472-6750/6/29
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Legocki et al. [28] have demonstrated that an immuno-
protective response is induced in mice by oral administra-
tion of E2 glycoprotein produced in planta. Epitope
mapping studies have begun to identify the minimal
immunogenic site of various monoclonal or polyclonal
antibodies directed against the E2 protein. The mass pro-
duction of specific E2 peptides will be needed to improve
the specificity of diagnostic kits and to induce highly spe-
cific immunization. Owing to the high speed of plant viral
expression systems and to the ease of recovery of PVX
recombinant viral particles, we believe that the expression
system described could be extremely useful.
Recently, Uhde et al. [18] and Marusic et al. [16] have
demonstrated that small peptides shorter than 15 amino
acids can be expressed if directly linked to the N-terminus
of the PVX-CP. Other studies have shown that with the
2A-based overcoating strategy, the PVX can be used as a
presentation system for proteins or peptides such as green
fluorescent protein [22], the highly conserved ELDKWA
peptide from glycoprotein 41 of scFv [29] and rotavirus
major capsid protein (VP6) [30] but no direct assessment
of insert stability was reported. Our study demonstrated
that the 2A based overcoating strategy allows to express
peptides long up to 70 aa without a significant loss of
insert.
Further studies are required to verify whether a size con-
strain on insert length exists. In addition, other factors
related to insert sequence may further influence insert sta-
bility. For example, the presence of recombinationally
active sequence (RAS), i.e regions of homology between
the insert and part of the vector or the formation of local
double stranded regions within the insert sequence were
demonstrated to promote heterologous recombination
[31].
Our ongoing experiments are aimed towards optimiza-
tion of two-step purification procedures that will allow
both recovery of recombinant virions by PEG precipita-
tion and purification of the uncleaved 6His-epitope-CP
polyprotein by anti 6His affinity chromatography.
Finally, concerns may be raised regarding the safety of this
expression system in regions where either tobacco or
potato are widely cultivated. In addressing this issue, it is
useful to stress that there is no evidence that naturally
occurring vectors (insect, nematodes or fungal) transmit
PVX. Moreover, the virus is not transmitted through seed
or pollen and thus the risk of its accidental release into the
environment is exceedingly small. Therefore, environ-
mentally safe conditions could be easily obtained with a
moderate investment in infrastructures.
Methods
Double stranded oligolinkers
To express peptides fused to PVX coat protein (CP), an in-
frame sequence encoding 16 amino acids of the 2A oli-
gopeptide (NFDLLKLAGDVESNPG) of the Foot-and
Mouth Disease Virus (FMDV) [32], was cloned between
the 3' end of a sequence encoding for a 6 Histidine tag
(6His) and the fourth codon of the coat protein coding
sequence (CDS) (Fig. 1). Transcription of the chimeric
messenger was driven by a duplicated CP promoter of PVX
[33]. The double-stranded 2A oligolinker was prepared by
mixing 500 pmol of the 2A upper (5'-
TCGACAATTTTGATTTATTAAAGTTAGCAGGTGATGTT-
GAATACAATCCAGGTCCAG-3') and 2A lower (5'-
CTGGACCTGGATTTGATTCAACATCACCTGCTAACTT-
TAATAAATCAAAATTGTCGA-3') oligos. The 6His-tag
double stranded oligolinker was prepared by mixing 500
pmol of 6His upper (5'-TCGAGATGCACCACCACCAC-
CACCACG-3') and 6His lower (5'-TCGACGTGGTGGT-
GGTGGTGGTGCATC-3') oligos. The oligonucleotide
mixtures were heated at 95°C for 10 min and then cooled
at room temperature to allow annealing.
Construction of PVX6His2ACP vector
The PVX201 vector (kindly provided by David Baul-
combe, The Sainsbury Laboratory, Norwich, UK, [34])
which contains the PVX cDNA under the transcriptional
control of the Cauliflower 35S promoter and the nopaline
Both uncleaved and cleaved CP protein are produced Figure 4
Both uncleaved and cleaved CP protein are pro-
duced. Western blotting analysis carried out on protein 
extracts using a rabbit polyclonal anti-CP antibody (A and B) 
and a mouse monoclonal anti-6His antibody (C and D). Fif-
teen micrograms of protein were prepared from mock-inoc-
ulated control plants (A2, B2, C2 and D2), plants inoculated 
with PVX6His2ACP (A3, B3, C3 and D3), plants inoculated 
with PVX6HisE212ACP (A1 and C1) or with 
PVX6HisE222ACP (B1 and D1). Standards Molecular weight 
are shown on the left of each figure (kDa = kiloDaltons).BMC Biotechnology 2006, 6:29 http://www.biomedcentral.com/1472-6750/6/29
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synthase terminator [33] was digested with NheI (New
England Biolabs) and then blunt-ended by Klenow
polymerase (New England Biolabs). The linearized vector
was then ligated to the 2A double stranded oligolinker to
produce the PVX2ACP vector.
The PVX2ACP vector was then linearized with SalI and
ligated to the 6His-tag oligolinker to produce the
PVX6His2ACP vector. This vector contains a unique SalI
site to be used for cloning coding sequences for the gene
of interest that is fused in frame to the 3' terminus of the
6His-tag and to the 5' end of the 2A sequence.
Construction of PVX6HisE212ACP and PVX6HisE222ACP
The E21 (region between amino acids 790 and 860) and
E22 (region between amino acids 854 and 894) sequences
of the E2 protein were amplified by PCR using specific
primers (Table 1) that contained a SalI site to allow subse-
quent cloning into PVX6His2ACP.
The amplification fragments were cloned into a PCR4
TOPO vector using the TOPO TA cloning for sequencing
kit (Invitrogen) and sequenced to verify the absence of
point mutations. The E21 and E22 fragments were excised
from the respective PCR4 vectors using SalI and separated
on a 1% agarose gel. The bands were then purified from
the gel using the GFX™ PCR DNA and Gel Band Purifica-
tion kit (Amersham Biosciences).
The PVX6His2ACP vector, linearized with SalI and
dephosphorylated using calf intestinal alkaline phos-
phatase (New England Biolabs), was ligated to either the
E21 or E22 fragments to produce PVX6HisE212ACP and
PVX6HisE222ACP, respectively.
Plant infection and RT-PCR analysis
Nicotiana benthamiana plants were grown at 22°C with a
day-light cycle of 16 h of light and 8 h of dark. Two
healthy leaves per plant were infected using 20 µg of either
PVX6His2ACP, PVX6HisE212ACP or PVX6HisE222ACP
plasmid as described by Marusic et al. [16].
Total RNAs were isolated from symptomatic leaves two
weeks after the infection using the GenElute Mammalian
Total RNA miniprep kit (Sigma) according to the manu-
facturer's instructions. Total RNA was purified from resid-
ual genomic DNA using the DNA-free kit (Ambion). First
strand cDNA was synthesized from 1 µg of total RNA in a
volume of 50 µl according to Sambrook and Russell [35].
RT-PCR reactions were performed in a total volume of 50
µl containing 1 µl of first-strand cDNA, 1 µM of each
primer, 1× PCR buffer, 1.5 mM MgCl2, 0.2 µM dNTPs and
2 U of recombinant Taq DNA polymerase (Invitrogen).
The DNA was denatured at 94°C for 1 min, and then sub-
jected to 25 cycles of 94°C for 1 min, Tm (specific for each
primer pair, Table 1) for 1 min and 72°C for 1 min, plus
a final extension at 72°C for 10 min. Table 1 gives the
sequence of primers used for RT-PCR experiments (Fig. 2).
Sequencing was performed using an ABI Prism 377
(Applied Biosystems) and the ABI Prism Big Dye Termina-
tor v1.1 Ready Reaction Cycle Sequencing kit (Applied
Biosystems). Primers used for sequencing reactions were
PVX FOR and PVX REW (Table 1).
Protein extraction and quantification
N. benthamiana leaves were ground to a fine powder in liq-
uid nitrogen. Approximately 0.5 g of leaf powder was
resuspended in 0.7 ml of extraction buffer (50 mM Tris-
HCl, 150 mM NaCl, 1 mM PMSF, 0.2% Triton X-100, pH
Purified virions are immunogenic Figure 5
Purified virions are immunogenic. Staining with Comassie Brilliant Blue (A) of mock-inoculated control plants (A1), par-
tially purified viral particles of the PVX6HisE212ACP (A2) and PVX6His2ACP (A3). Western blotting with anti-6His (B upper) 
and anti-CP (B lower) antibodies of partially purified viral particles of the PVX6HisE212ACP (B1) and PVX6His2ACP (B2). 
Western blotting analysis (C) using sera from rabbit inoculated with PVX6His2ACP against proteins purified from mock-inocu-
lated control plants (C1) and from PVX6His2ACP (C2). Western blotting analysis (D) using sera from rabbit inoculated with 
PVX6HisE212ACP. Purified E2 protein (D1; E2 control protein is indicated with a bold arrow), marker (D2), proteins purified 
from plants inoculated with PVX6HisE212ACP (D3), mock-inoculated control plants (D4) and PVX6His2ACP (D5). Standards 
Molecular weight (kDa = kiloDaltons) are shown on the left of each figure.BMC Biotechnology 2006, 6:29 http://www.biomedcentral.com/1472-6750/6/29
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8). The homogenates were centrifuged at 15,000 × g at
4°C for 20 min and the supernatants were quantified
using the Bradford protein assay kit (Bio-Rad) using
Bovine Serum Albumin (BSA) as reference standard.
SDS/PAGE and Western blotting analysis
Equal amounts of total soluble proteins have been loaded
on 12% SDS-polyacrylamide gels according to Sambrook
and Russell [35]. Gels were either stained with Coomassie
Brilliant Blue (Bio-Rad) according to Sambrook and Rus-
sell [35] or transferred to a Hybond C+ membrane (Amer-
sham) using a semidry blotting apparatus (Bio-Rad) at 20
V for 12 h at 4°C. The membranes were blocked with 10%
non-fat dry milk (Bio-Rad) in T-TBS for 1 h at room tem-
perature. A 1: 10,000 rabbit polyclonal anti-CP antibody
(1:10,000; kindly provided by CNR-IVV) and an anti-rab-
bit IgG peroxidase conjugated (1:5,000; Sigma) were used
as primary and secondary antibodies, respectively. A
mouse monoclonal anti-6His antibody (1:3,000; BD Bio-
sciences) and an anti-mouse peroxidase conjugate
(1:10,000; Sigma) were used for Western blotting.
Hybridized blots were exposed with Kodak AR films
(Kodak) after the chemiluminescent reaction carried out
using the ECL kit (Pierce).
Partial purification of PVX particles
Virus particles were purified from plant leaves infected
with PVX6His2ACP or PVX6HisE212ACP according to a
modified method of AbouHaidar et al. [23]. Briefly, pow-
dered infected leaves (5 g) were suspended in 20 ml Tris-
borate buffer containing 0.2% β-mercaptoethanol. The
suspension was filtered through four layers of cheesecloth
and n-butanol was added to a final concentration of 6%.
The mixture was kept on ice for 2 h with constant stirring
and then centrifuged for 10 min at 15,000 × g. PEG 8,000
was added to a final concentration of 8% in the presence
of 2% NaCl on ice for 2 h with constant stirring, decanted
for another 2 h, and then centrifuged at 15,000 × g for 10
min. The pellet was resuspended in Tris-borate buffer, pH
7.5 at 4°C overnight. The virus solution was then centri-
fuged three times at 7,500 × g for 5 min each. After precip-
itation, particles were directly dialyzed against 1× PBS.
The concentration of virus was calculated using the PVX
extinction coefficient (2.97) at 260 nm as reported by
Uhde et al. [18].
Rabbit immunizations
Three months old rabbits (New Zealand Breed) were
divided in groups A, B and C of four rabbits each and
injected by subcutaneous route using 50 µg of purified
proteins containing Freund's adjuvant. Immunizations
were repeated after 21 and 45 days without adjuvants. The
A group was immunized with PVX6HisE212ACP, the B
group with PBS only and C group with PVX6His2ACP
purified virions. Fifteen days after the last immunization,
rabbits were bled and serum was recovered. Preimmune
sera (Fig 6A and 6E) and sera dilutions (1/10, 1/100, 1/
1000) from A and C groups (Fig. 6B–D and 6F–H) were
then tested for antibody reactivity against E2 following
standard procedure. E2 protein was specifically recog-
nized only by sera from A group rabbit dilutions up to 1/
100 (Fig. 6B–D). Baculovirus produced E2 protein, kindly
provided by the Italian Reference Centre for Classical
Swine Fever (Istituto Zooprofilattico dell'Umbria e delle
Marche), was resuspended in sample buffer and loaded in
12% SDS-PAGE and blotted to Hybond C+ membrane
(Amersham).
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Sera from immunized rabbits contain anti-E2-specific anti- bodies Figure 6
Sera from immunized rabbits contain anti-E2-specific 
antibodies. Pre-immune sera (A and E) and sera from rabbit 
immunized with PVX6HisE212ACP (B, C, D) and with 
PVX6His2ACP (F, G, H) were tested by Western blotting for 
antibody reactivity against E2 (indicated with a bold arrow) 
protein (lanes A2, B2, C2, D2, E2, F2, G2 and H2). Western 
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